Retatrutide 20mg
Retatrutide 20mg is a synthetic peptide investigated in controlled laboratory studies of metabolic regulation and multi-receptor signaling. Research models examine its interaction with GLP-1, GIP, and glucagon pathways, making it relevant to studies of peptide activity and metabolic mechanisms. For Research Use Only. Not for human or animal use. Not FDA evaluated.
Metabolic — Triple Receptor Agonist
The following compounds operate through distinct, non-overlapping mechanisms that complement this product's research pathways. Each is independently available from the General Peptide catalog.
Cagrilintide 10mg is a synthetic peptide studied in laboratory research focused on amylin receptor signaling and metabolic pathways. Supplied as a lyophilized powder and HPLC-verified for purity, it supports controlled research into peptide act...
Tirzepatide 30mg is supplied as a lyophilized powder for controlled laboratory research. Its defined composition is suitable for analytical studies involving GIP and GLP-1 receptor signaling, peptide characterization, and metabolic research mod...
MOTS-C 40mg is supplied as a lyophilized mitochondrial-derived peptide for controlled laboratory research. This 16-amino-acid peptide is studied in research models involving cellular energy sensing, metabolic signaling, and mitochondrial pathwa...